Gastrointestinal Involvement in Chagas Disease
- Autores
- Bilder, Claudio Rubén; Goin, Juan Carlos
- Año de publicación
- 2017
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Achalasia and megacolon are the second most common manifestations of chronic Chagas disease (ChD) in endemic areas of Central and South America. Twenty or even more years after the initial infection, approximately one-third of infected people develop cardiac and/ or gastrointestinal abnormalities as typical chronic damages of ChD. The chronic phase of ChD is characterized by the damage of myenteric (intrinsic) and autonomic (extrinsic) neurons. A decreased density of enteric glial cells can be detected in patients with megaesophagus and megacolon and a loss of interstitial cells of Cajal in the latter patients. These lesions affect the complex mechanisms of neural, molecular, and cellular interactions that modulate the motor activity and other specific functions of the alimentary tract. Evidence for serum antibodies with the ability to recognize similar epitopes in both Trypanosoma cruzi and host antigens suggested that molecular mimicry could play a substantial role in the pathophysiology of chronic ChD. In fact, a high prevalence of circulating antibodies against M2 acetylcholine muscarinic receptor (M2R) in ChD patients with achalasia and megacolon has been found. These antibodies bind to and activate M2R, exhibiting agonist-like activity. Anti-M2R antibodies can both enhance tonic contraction in lower esophagus and distal colon by direct stimulation and also by counteracting the relaxant effect of drugs that increase cAMP accumulation (i.e. beta-adrenergic agonists). The biochemical and functional effects of these antibodies on esophageal and colon smooth muscle could play an important role in the pathophysiology of achalasia and megacolon secondary to ChD.
Fil: Bilder, Claudio Rubén. Universidad Favaloro. Facultad de Medicina; Argentina
Fil: Goin, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina - Materia
-
CHAGAS
ACHALASIA
MEGACOLON
MUSCARINIC ANTIBODIES - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/49578
Ver los metadatos del registro completo
id |
CONICETDig_39ea2ac4ab448a04a38513ad19d3027e |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/49578 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Gastrointestinal Involvement in Chagas DiseaseBilder, Claudio RubénGoin, Juan CarlosCHAGASACHALASIAMEGACOLONMUSCARINIC ANTIBODIEShttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Achalasia and megacolon are the second most common manifestations of chronic Chagas disease (ChD) in endemic areas of Central and South America. Twenty or even more years after the initial infection, approximately one-third of infected people develop cardiac and/ or gastrointestinal abnormalities as typical chronic damages of ChD. The chronic phase of ChD is characterized by the damage of myenteric (intrinsic) and autonomic (extrinsic) neurons. A decreased density of enteric glial cells can be detected in patients with megaesophagus and megacolon and a loss of interstitial cells of Cajal in the latter patients. These lesions affect the complex mechanisms of neural, molecular, and cellular interactions that modulate the motor activity and other specific functions of the alimentary tract. Evidence for serum antibodies with the ability to recognize similar epitopes in both Trypanosoma cruzi and host antigens suggested that molecular mimicry could play a substantial role in the pathophysiology of chronic ChD. In fact, a high prevalence of circulating antibodies against M2 acetylcholine muscarinic receptor (M2R) in ChD patients with achalasia and megacolon has been found. These antibodies bind to and activate M2R, exhibiting agonist-like activity. Anti-M2R antibodies can both enhance tonic contraction in lower esophagus and distal colon by direct stimulation and also by counteracting the relaxant effect of drugs that increase cAMP accumulation (i.e. beta-adrenergic agonists). The biochemical and functional effects of these antibodies on esophageal and colon smooth muscle could play an important role in the pathophysiology of achalasia and megacolon secondary to ChD.Fil: Bilder, Claudio Rubén. Universidad Favaloro. Facultad de Medicina; ArgentinaFil: Goin, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; ArgentinaPermanyer2017-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/49578Bilder, Claudio Rubén; Goin, Juan Carlos; Gastrointestinal Involvement in Chagas Disease; Permanyer; NeuroGastroLATAM Reviews; 1; 12-2017; 168-1792462-7011CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://www.neurogastrolatamreviews.com/files/nglr_2017_1_4_168-179.pdfinfo:eu-repo/semantics/altIdentifier/doi/10.24875/NGL.17000002info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T12:09:12Zoai:ri.conicet.gov.ar:11336/49578instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 12:09:13.072CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Gastrointestinal Involvement in Chagas Disease |
title |
Gastrointestinal Involvement in Chagas Disease |
spellingShingle |
Gastrointestinal Involvement in Chagas Disease Bilder, Claudio Rubén CHAGAS ACHALASIA MEGACOLON MUSCARINIC ANTIBODIES |
title_short |
Gastrointestinal Involvement in Chagas Disease |
title_full |
Gastrointestinal Involvement in Chagas Disease |
title_fullStr |
Gastrointestinal Involvement in Chagas Disease |
title_full_unstemmed |
Gastrointestinal Involvement in Chagas Disease |
title_sort |
Gastrointestinal Involvement in Chagas Disease |
dc.creator.none.fl_str_mv |
Bilder, Claudio Rubén Goin, Juan Carlos |
author |
Bilder, Claudio Rubén |
author_facet |
Bilder, Claudio Rubén Goin, Juan Carlos |
author_role |
author |
author2 |
Goin, Juan Carlos |
author2_role |
author |
dc.subject.none.fl_str_mv |
CHAGAS ACHALASIA MEGACOLON MUSCARINIC ANTIBODIES |
topic |
CHAGAS ACHALASIA MEGACOLON MUSCARINIC ANTIBODIES |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Achalasia and megacolon are the second most common manifestations of chronic Chagas disease (ChD) in endemic areas of Central and South America. Twenty or even more years after the initial infection, approximately one-third of infected people develop cardiac and/ or gastrointestinal abnormalities as typical chronic damages of ChD. The chronic phase of ChD is characterized by the damage of myenteric (intrinsic) and autonomic (extrinsic) neurons. A decreased density of enteric glial cells can be detected in patients with megaesophagus and megacolon and a loss of interstitial cells of Cajal in the latter patients. These lesions affect the complex mechanisms of neural, molecular, and cellular interactions that modulate the motor activity and other specific functions of the alimentary tract. Evidence for serum antibodies with the ability to recognize similar epitopes in both Trypanosoma cruzi and host antigens suggested that molecular mimicry could play a substantial role in the pathophysiology of chronic ChD. In fact, a high prevalence of circulating antibodies against M2 acetylcholine muscarinic receptor (M2R) in ChD patients with achalasia and megacolon has been found. These antibodies bind to and activate M2R, exhibiting agonist-like activity. Anti-M2R antibodies can both enhance tonic contraction in lower esophagus and distal colon by direct stimulation and also by counteracting the relaxant effect of drugs that increase cAMP accumulation (i.e. beta-adrenergic agonists). The biochemical and functional effects of these antibodies on esophageal and colon smooth muscle could play an important role in the pathophysiology of achalasia and megacolon secondary to ChD. Fil: Bilder, Claudio Rubén. Universidad Favaloro. Facultad de Medicina; Argentina Fil: Goin, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Centro de Estudios Farmacológicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios Farmacológicos y Botánicos; Argentina |
description |
Achalasia and megacolon are the second most common manifestations of chronic Chagas disease (ChD) in endemic areas of Central and South America. Twenty or even more years after the initial infection, approximately one-third of infected people develop cardiac and/ or gastrointestinal abnormalities as typical chronic damages of ChD. The chronic phase of ChD is characterized by the damage of myenteric (intrinsic) and autonomic (extrinsic) neurons. A decreased density of enteric glial cells can be detected in patients with megaesophagus and megacolon and a loss of interstitial cells of Cajal in the latter patients. These lesions affect the complex mechanisms of neural, molecular, and cellular interactions that modulate the motor activity and other specific functions of the alimentary tract. Evidence for serum antibodies with the ability to recognize similar epitopes in both Trypanosoma cruzi and host antigens suggested that molecular mimicry could play a substantial role in the pathophysiology of chronic ChD. In fact, a high prevalence of circulating antibodies against M2 acetylcholine muscarinic receptor (M2R) in ChD patients with achalasia and megacolon has been found. These antibodies bind to and activate M2R, exhibiting agonist-like activity. Anti-M2R antibodies can both enhance tonic contraction in lower esophagus and distal colon by direct stimulation and also by counteracting the relaxant effect of drugs that increase cAMP accumulation (i.e. beta-adrenergic agonists). The biochemical and functional effects of these antibodies on esophageal and colon smooth muscle could play an important role in the pathophysiology of achalasia and megacolon secondary to ChD. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/49578 Bilder, Claudio Rubén; Goin, Juan Carlos; Gastrointestinal Involvement in Chagas Disease; Permanyer; NeuroGastroLATAM Reviews; 1; 12-2017; 168-179 2462-7011 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/49578 |
identifier_str_mv |
Bilder, Claudio Rubén; Goin, Juan Carlos; Gastrointestinal Involvement in Chagas Disease; Permanyer; NeuroGastroLATAM Reviews; 1; 12-2017; 168-179 2462-7011 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.neurogastrolatamreviews.com/files/nglr_2017_1_4_168-179.pdf info:eu-repo/semantics/altIdentifier/doi/10.24875/NGL.17000002 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Permanyer |
publisher.none.fl_str_mv |
Permanyer |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1846782468875616256 |
score |
12.928904 |